Trial Profile
Autologous Stem Cell Therapy for the Treatment of Patients With Peripheral Artery Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ACP 01 (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Salus Ltd
- 15 Apr 2015 New trial record